nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—migraine—Prednisone—multiple sclerosis	0.143	0.341	CpDpCtD
Indomethacin—osteoarthritis—Methylprednisolone—multiple sclerosis	0.138	0.33	CpDpCtD
Indomethacin—osteoarthritis—Prednisone—multiple sclerosis	0.138	0.33	CpDpCtD
Indomethacin—ALB—multiple sclerosis	0.0734	1	CbGaD
Indomethacin—ABCC11—Methotrexate—multiple sclerosis	0.0547	0.17	CbGbCtD
Indomethacin—ABCC1—Mitoxantrone—multiple sclerosis	0.0222	0.0692	CbGbCtD
Indomethacin—SLCO1A2—Prednisolone—multiple sclerosis	0.0175	0.0544	CbGbCtD
Indomethacin—PTGS2—Triamcinolone—multiple sclerosis	0.0169	0.0526	CbGbCtD
Indomethacin—SLCO1A2—Prednisone—multiple sclerosis	0.0165	0.0513	CbGbCtD
Indomethacin—ABCC3—Methotrexate—multiple sclerosis	0.0151	0.047	CbGbCtD
Indomethacin—PTGS2—Betamethasone—multiple sclerosis	0.0145	0.0451	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—multiple sclerosis	0.0124	0.0386	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—multiple sclerosis	0.0118	0.0367	CbGbCtD
Indomethacin—ABCC4—Methotrexate—multiple sclerosis	0.0115	0.0359	CbGbCtD
Indomethacin—SLCO1A2—Dexamethasone—multiple sclerosis	0.0103	0.0321	CbGbCtD
Indomethacin—ABCC1—Methotrexate—multiple sclerosis	0.00927	0.0289	CbGbCtD
Indomethacin—ABCC2—Dexamethasone—multiple sclerosis	0.00854	0.0266	CbGbCtD
Indomethacin—ALB—Prednisone—multiple sclerosis	0.00852	0.0265	CbGbCtD
Indomethacin—PTGS2—Dexamethasone—multiple sclerosis	0.00843	0.0263	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—multiple sclerosis	0.00827	0.0258	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—multiple sclerosis	0.00781	0.0243	CbGbCtD
Indomethacin—ABCB1—Methylprednisolone—multiple sclerosis	0.00736	0.0229	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—multiple sclerosis	0.00721	0.0224	CbGbCtD
Indomethacin—ABCC2—Methotrexate—multiple sclerosis	0.00686	0.0214	CbGbCtD
Indomethacin—CYP2C19—Prednisone—multiple sclerosis	0.00552	0.0172	CbGbCtD
Indomethacin—ABCB1—Mitoxantrone—multiple sclerosis	0.00537	0.0167	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—multiple sclerosis	0.00502	0.0156	CbGbCtD
Indomethacin—ABCB1—Betamethasone—multiple sclerosis	0.00478	0.0149	CbGbCtD
Indomethacin—ABCB1—Prednisolone—multiple sclerosis	0.00472	0.0147	CbGbCtD
Indomethacin—ABCB1—Prednisone—multiple sclerosis	0.00446	0.0139	CbGbCtD
Indomethacin—ALB—Methotrexate—multiple sclerosis	0.00427	0.0133	CbGbCtD
Indomethacin—CYP2C19—Dexamethasone—multiple sclerosis	0.00345	0.0107	CbGbCtD
Indomethacin—CYP2C9—Dexamethasone—multiple sclerosis	0.00287	0.00893	CbGbCtD
Indomethacin—ABCB1—Dexamethasone—multiple sclerosis	0.00278	0.00866	CbGbCtD
Indomethacin—ABCB1—Methotrexate—multiple sclerosis	0.00224	0.00696	CbGbCtD
Indomethacin—PPARG—leg—multiple sclerosis	0.00164	0.0566	CbGeAlD
Indomethacin—PTGDR2—cerebellum—multiple sclerosis	0.000961	0.0332	CbGeAlD
Indomethacin—PTGR2—medulla oblongata—multiple sclerosis	0.000903	0.0312	CbGeAlD
Indomethacin—PTGS2—leg—multiple sclerosis	0.000837	0.0289	CbGeAlD
Indomethacin—PTGR2—midbrain—multiple sclerosis	0.000825	0.0285	CbGeAlD
Indomethacin—PTGR2—spinal cord—multiple sclerosis	0.000805	0.0278	CbGeAlD
Indomethacin—PTGDR2—brain—multiple sclerosis	0.000781	0.027	CbGeAlD
Indomethacin—GLO1—retina—multiple sclerosis	0.000771	0.0266	CbGeAlD
Indomethacin—ABCC6—retina—multiple sclerosis	0.00071	0.0245	CbGeAlD
Indomethacin—PTGR2—nervous system—multiple sclerosis	0.000678	0.0234	CbGeAlD
Indomethacin—PPARA—retina—multiple sclerosis	0.00067	0.0231	CbGeAlD
Indomethacin—PTGR2—central nervous system—multiple sclerosis	0.000653	0.0225	CbGeAlD
Indomethacin—PTGR2—cerebellum—multiple sclerosis	0.000638	0.022	CbGeAlD
Indomethacin—GLO1—medulla oblongata—multiple sclerosis	0.000558	0.0193	CbGeAlD
Indomethacin—PTGR2—brain—multiple sclerosis	0.000518	0.0179	CbGeAlD
Indomethacin—CXCL8—medulla oblongata—multiple sclerosis	0.000513	0.0177	CbGeAlD
Indomethacin—GLO1—midbrain—multiple sclerosis	0.00051	0.0176	CbGeAlD
Indomethacin—GLO1—spinal cord—multiple sclerosis	0.000497	0.0172	CbGeAlD
Indomethacin—PLA2G2A—midbrain—multiple sclerosis	0.000474	0.0164	CbGeAlD
Indomethacin—CXCL8—midbrain—multiple sclerosis	0.000469	0.0162	CbGeAlD
Indomethacin—CXCL8—spinal cord—multiple sclerosis	0.000458	0.0158	CbGeAlD
Indomethacin—GLO1—nervous system—multiple sclerosis	0.000419	0.0145	CbGeAlD
Indomethacin—GLO1—central nervous system—multiple sclerosis	0.000403	0.0139	CbGeAlD
Indomethacin—AKR1C3—medulla oblongata—multiple sclerosis	0.000402	0.0139	CbGeAlD
Indomethacin—GLO1—cerebellum—multiple sclerosis	0.000394	0.0136	CbGeAlD
Indomethacin—PLA2G2A—nervous system—multiple sclerosis	0.000389	0.0135	CbGeAlD
Indomethacin—PLA2G2A—central nervous system—multiple sclerosis	0.000375	0.0129	CbGeAlD
Indomethacin—AKR1C3—midbrain—multiple sclerosis	0.000368	0.0127	CbGeAlD
Indomethacin—PPARA—nervous system—multiple sclerosis	0.000364	0.0126	CbGeAlD
Indomethacin—CXCL8—cerebellum—multiple sclerosis	0.000363	0.0125	CbGeAlD
Indomethacin—AKR1C3—spinal cord—multiple sclerosis	0.000359	0.0124	CbGeAlD
Indomethacin—PPARA—central nervous system—multiple sclerosis	0.00035	0.0121	CbGeAlD
Indomethacin—SLC10A1—nervous system—multiple sclerosis	0.00035	0.0121	CbGeAlD
Indomethacin—PPARA—cerebellum—multiple sclerosis	0.000342	0.0118	CbGeAlD
Indomethacin—SLC10A1—central nervous system—multiple sclerosis	0.000337	0.0116	CbGeAlD
Indomethacin—GLO1—brain—multiple sclerosis	0.00032	0.0111	CbGeAlD
Indomethacin—PLA2G2A—brain—multiple sclerosis	0.000298	0.0103	CbGeAlD
Indomethacin—CXCL8—brain—multiple sclerosis	0.000295	0.0102	CbGeAlD
Indomethacin—AKR1C3—cerebellum—multiple sclerosis	0.000284	0.00982	CbGeAlD
Indomethacin—PPARA—brain—multiple sclerosis	0.000278	0.0096	CbGeAlD
Indomethacin—CES1—nervous system—multiple sclerosis	0.00027	0.00932	CbGeAlD
Indomethacin—SLC10A1—brain—multiple sclerosis	0.000267	0.00923	CbGeAlD
Indomethacin—CES1—central nervous system—multiple sclerosis	0.00026	0.00898	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000254	0.159	CbGdCrCtD
Indomethacin—SLCO1A2—medulla oblongata—multiple sclerosis	0.000251	0.00868	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.00025	0.156	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.00025	0.156	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000244	0.153	CbGdCrCtD
Indomethacin—SLC22A7—brain—multiple sclerosis	0.000238	0.00823	CbGeAlD
Indomethacin—AKR1C3—brain—multiple sclerosis	0.000231	0.00798	CbGeAlD
Indomethacin—SLC22A6—brain—multiple sclerosis	0.00023	0.00795	CbGeAlD
Indomethacin—SLCO1A2—midbrain—multiple sclerosis	0.00023	0.00793	CbGeAlD
Indomethacin—SLCO1A2—spinal cord—multiple sclerosis	0.000224	0.00774	CbGeAlD
Indomethacin—ABCC3—nervous system—multiple sclerosis	0.00022	0.0076	CbGeAlD
Indomethacin—ABCC3—central nervous system—multiple sclerosis	0.000212	0.00732	CbGeAlD
Indomethacin—CES1—brain—multiple sclerosis	0.000206	0.00713	CbGeAlD
Indomethacin—PPARG—nervous system—multiple sclerosis	0.0002	0.00691	CbGeAlD
Indomethacin—PPARG—central nervous system—multiple sclerosis	0.000193	0.00665	CbGeAlD
Indomethacin—SLCO1A2—nervous system—multiple sclerosis	0.000189	0.00652	CbGeAlD
Indomethacin—SLCO1A2—central nervous system—multiple sclerosis	0.000182	0.00628	CbGeAlD
Indomethacin—ABCC4—nervous system—multiple sclerosis	0.000182	0.00627	CbGeAlD
Indomethacin—SLC22A8—nervous system—multiple sclerosis	0.00018	0.00622	CbGeAlD
Indomethacin—SLCO1A2—cerebellum—multiple sclerosis	0.000178	0.00613	CbGeAlD
Indomethacin—ABCC4—central nervous system—multiple sclerosis	0.000175	0.00604	CbGeAlD
Indomethacin—SLC22A8—central nervous system—multiple sclerosis	0.000174	0.00599	CbGeAlD
Indomethacin—ABCC3—brain—multiple sclerosis	0.000168	0.00581	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000153	0.0958	CbGdCrCtD
Indomethacin—PPARG—brain—multiple sclerosis	0.000153	0.00528	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000151	0.0942	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000151	0.0942	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000147	0.0921	CbGdCrCtD
Indomethacin—ABCC1—cerebellum—multiple sclerosis	0.000146	0.00503	CbGeAlD
Indomethacin—SLCO1A2—brain—multiple sclerosis	0.000144	0.00498	CbGeAlD
Indomethacin—ALB—brain—multiple sclerosis	0.000143	0.00495	CbGeAlD
Indomethacin—ABCC4—brain—multiple sclerosis	0.000139	0.0048	CbGeAlD
Indomethacin—SLC22A8—brain—multiple sclerosis	0.000138	0.00476	CbGeAlD
Indomethacin—PTGS2—medulla oblongata—multiple sclerosis	0.000136	0.0047	CbGeAlD
Indomethacin—PTGS1—spinal cord—multiple sclerosis	0.000127	0.00438	CbGeAlD
Indomethacin—PTGS2—midbrain—multiple sclerosis	0.000124	0.00429	CbGeAlD
Indomethacin—PTGS2—spinal cord—multiple sclerosis	0.000121	0.00419	CbGeAlD
Indomethacin—ABCC1—brain—multiple sclerosis	0.000118	0.00409	CbGeAlD
Indomethacin—ABCB1—retina—multiple sclerosis	0.000116	0.00402	CbGeAlD
Indomethacin—PTGS1—nervous system—multiple sclerosis	0.000107	0.00369	CbGeAlD
Indomethacin—PTGS1—central nervous system—multiple sclerosis	0.000103	0.00356	CbGeAlD
Indomethacin—PTGS2—nervous system—multiple sclerosis	0.000102	0.00353	CbGeAlD
Indomethacin—PTGS2—central nervous system—multiple sclerosis	9.84e-05	0.0034	CbGeAlD
Indomethacin—PTGS2—cerebellum—multiple sclerosis	9.62e-05	0.00332	CbGeAlD
Indomethacin—ABCB1—medulla oblongata—multiple sclerosis	8.42e-05	0.00291	CbGeAlD
Indomethacin—PTGS1—brain—multiple sclerosis	8.17e-05	0.00282	CbGeAlD
Indomethacin—PTGS2—brain—multiple sclerosis	7.81e-05	0.0027	CbGeAlD
Indomethacin—ABCB1—midbrain—multiple sclerosis	7.69e-05	0.00266	CbGeAlD
Indomethacin—ABCB1—spinal cord—multiple sclerosis	7.5e-05	0.00259	CbGeAlD
Indomethacin—Hyperhidrosis—Prednisolone—multiple sclerosis	7.07e-05	0.000849	CcSEcCtD
Indomethacin—Abdominal pain—Mitoxantrone—multiple sclerosis	7.05e-05	0.000846	CcSEcCtD
Indomethacin—Body temperature increased—Mitoxantrone—multiple sclerosis	7.05e-05	0.000846	CcSEcCtD
Indomethacin—Vomiting—Azathioprine—multiple sclerosis	7.02e-05	0.000841	CcSEcCtD
Indomethacin—Anxiety—Methylprednisolone—multiple sclerosis	6.98e-05	0.000837	CcSEcCtD
Indomethacin—Drowsiness—Methotrexate—multiple sclerosis	6.97e-05	0.000836	CcSEcCtD
Indomethacin—Rash—Azathioprine—multiple sclerosis	6.96e-05	0.000834	CcSEcCtD
Indomethacin—Dermatitis—Azathioprine—multiple sclerosis	6.95e-05	0.000834	CcSEcCtD
Indomethacin—Depression—Methotrexate—multiple sclerosis	6.95e-05	0.000833	CcSEcCtD
Indomethacin—Flushing—Prednisone—multiple sclerosis	6.95e-05	0.000833	CcSEcCtD
Indomethacin—Ill-defined disorder—Dexamethasone—multiple sclerosis	6.94e-05	0.000833	CcSEcCtD
Indomethacin—Ill-defined disorder—Betamethasone—multiple sclerosis	6.94e-05	0.000833	CcSEcCtD
Indomethacin—Discomfort—Triamcinolone—multiple sclerosis	6.94e-05	0.000832	CcSEcCtD
Indomethacin—Discomfort—Methylprednisolone—multiple sclerosis	6.92e-05	0.00083	CcSEcCtD
Indomethacin—Headache—Azathioprine—multiple sclerosis	6.91e-05	0.000829	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	6.91e-05	0.000829	CcSEcCtD
Indomethacin—Renal failure—Methotrexate—multiple sclerosis	6.85e-05	0.000822	CcSEcCtD
Indomethacin—Angioedema—Betamethasone—multiple sclerosis	6.84e-05	0.00082	CcSEcCtD
Indomethacin—Angioedema—Dexamethasone—multiple sclerosis	6.84e-05	0.00082	CcSEcCtD
Indomethacin—Stomatitis—Methotrexate—multiple sclerosis	6.79e-05	0.000815	CcSEcCtD
Indomethacin—Confusional state—Methylprednisolone—multiple sclerosis	6.77e-05	0.000812	CcSEcCtD
Indomethacin—Malaise—Dexamethasone—multiple sclerosis	6.75e-05	0.000809	CcSEcCtD
Indomethacin—Malaise—Betamethasone—multiple sclerosis	6.75e-05	0.000809	CcSEcCtD
Indomethacin—Anaphylactic shock—Triamcinolone—multiple sclerosis	6.73e-05	0.000807	CcSEcCtD
Indomethacin—Oedema—Triamcinolone—multiple sclerosis	6.73e-05	0.000807	CcSEcCtD
Indomethacin—Vertigo—Dexamethasone—multiple sclerosis	6.72e-05	0.000806	CcSEcCtD
Indomethacin—Vertigo—Betamethasone—multiple sclerosis	6.72e-05	0.000806	CcSEcCtD
Indomethacin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	6.71e-05	0.000805	CcSEcCtD
Indomethacin—Syncope—Dexamethasone—multiple sclerosis	6.71e-05	0.000805	CcSEcCtD
Indomethacin—Syncope—Betamethasone—multiple sclerosis	6.71e-05	0.000805	CcSEcCtD
Indomethacin—Arrhythmia—Prednisone—multiple sclerosis	6.69e-05	0.000802	CcSEcCtD
Indomethacin—Sweating—Methotrexate—multiple sclerosis	6.68e-05	0.000801	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—multiple sclerosis	6.64e-05	0.000797	CcSEcCtD
Indomethacin—Shock—Triamcinolone—multiple sclerosis	6.62e-05	0.000794	CcSEcCtD
Indomethacin—Insomnia—Prednisolone—multiple sclerosis	6.62e-05	0.000794	CcSEcCtD
Indomethacin—Alopecia—Prednisone—multiple sclerosis	6.61e-05	0.000793	CcSEcCtD
Indomethacin—Shock—Methylprednisolone—multiple sclerosis	6.61e-05	0.000792	CcSEcCtD
Indomethacin—Loss of consciousness—Betamethasone—multiple sclerosis	6.58e-05	0.000789	CcSEcCtD
Indomethacin—Loss of consciousness—Dexamethasone—multiple sclerosis	6.58e-05	0.000789	CcSEcCtD
Indomethacin—Epistaxis—Methotrexate—multiple sclerosis	6.57e-05	0.000788	CcSEcCtD
Indomethacin—Hypersensitivity—Mitoxantrone—multiple sclerosis	6.57e-05	0.000788	CcSEcCtD
Indomethacin—Paraesthesia—Prednisolone—multiple sclerosis	6.57e-05	0.000788	CcSEcCtD
Indomethacin—Tachycardia—Triamcinolone—multiple sclerosis	6.57e-05	0.000788	CcSEcCtD
Indomethacin—Nausea—Azathioprine—multiple sclerosis	6.55e-05	0.000786	CcSEcCtD
Indomethacin—Tachycardia—Methylprednisolone—multiple sclerosis	6.55e-05	0.000786	CcSEcCtD
Indomethacin—Erythema—Prednisone—multiple sclerosis	6.52e-05	0.000782	CcSEcCtD
Indomethacin—Hyperhidrosis—Triamcinolone—multiple sclerosis	6.51e-05	0.00078	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—multiple sclerosis	6.5e-05	0.00078	CcSEcCtD
Indomethacin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	6.49e-05	0.000779	CcSEcCtD
Indomethacin—Convulsion—Dexamethasone—multiple sclerosis	6.48e-05	0.000778	CcSEcCtD
Indomethacin—Convulsion—Betamethasone—multiple sclerosis	6.48e-05	0.000778	CcSEcCtD
Indomethacin—Hypertension—Betamethasone—multiple sclerosis	6.46e-05	0.000775	CcSEcCtD
Indomethacin—Hypertension—Dexamethasone—multiple sclerosis	6.46e-05	0.000775	CcSEcCtD
Indomethacin—Asthenia—Mitoxantrone—multiple sclerosis	6.4e-05	0.000768	CcSEcCtD
Indomethacin—Anxiety—Betamethasone—multiple sclerosis	6.35e-05	0.000761	CcSEcCtD
Indomethacin—Anxiety—Dexamethasone—multiple sclerosis	6.35e-05	0.000761	CcSEcCtD
Indomethacin—ABCB1—nervous system—multiple sclerosis	6.32e-05	0.00218	CbGeAlD
Indomethacin—Discomfort—Betamethasone—multiple sclerosis	6.29e-05	0.000755	CcSEcCtD
Indomethacin—Discomfort—Dexamethasone—multiple sclerosis	6.29e-05	0.000755	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—multiple sclerosis	6.29e-05	0.000754	CcSEcCtD
Indomethacin—Hypotension—Methylprednisolone—multiple sclerosis	6.27e-05	0.000753	CcSEcCtD
Indomethacin—Pain—Prednisolone—multiple sclerosis	6.26e-05	0.000751	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—multiple sclerosis	6.25e-05	0.00075	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—multiple sclerosis	6.25e-05	0.00075	CcSEcCtD
Indomethacin—Vision blurred—Prednisone—multiple sclerosis	6.14e-05	0.000737	CcSEcCtD
Indomethacin—Oedema—Dexamethasone—multiple sclerosis	6.11e-05	0.000732	CcSEcCtD
Indomethacin—Anaphylactic shock—Betamethasone—multiple sclerosis	6.11e-05	0.000732	CcSEcCtD
Indomethacin—Oedema—Betamethasone—multiple sclerosis	6.11e-05	0.000732	CcSEcCtD
Indomethacin—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.11e-05	0.000732	CcSEcCtD
Indomethacin—Diarrhoea—Mitoxantrone—multiple sclerosis	6.1e-05	0.000732	CcSEcCtD
Indomethacin—ABCB1—central nervous system—multiple sclerosis	6.09e-05	0.0021	CbGeAlD
Indomethacin—Insomnia—Triamcinolone—multiple sclerosis	6.09e-05	0.00073	CcSEcCtD
Indomethacin—Insomnia—Methylprednisolone—multiple sclerosis	6.07e-05	0.000728	CcSEcCtD
Indomethacin—Ill-defined disorder—Prednisone—multiple sclerosis	6.05e-05	0.000725	CcSEcCtD
Indomethacin—Paraesthesia—Triamcinolone—multiple sclerosis	6.04e-05	0.000725	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisolone—multiple sclerosis	6.03e-05	0.000723	CcSEcCtD
Indomethacin—Paraesthesia—Methylprednisolone—multiple sclerosis	6.03e-05	0.000723	CcSEcCtD
Indomethacin—Anaemia—Prednisone—multiple sclerosis	6.02e-05	0.000722	CcSEcCtD
Indomethacin—Shock—Dexamethasone—multiple sclerosis	6.01e-05	0.000721	CcSEcCtD
Indomethacin—Shock—Betamethasone—multiple sclerosis	6.01e-05	0.000721	CcSEcCtD
Indomethacin—Dyspnoea—Triamcinolone—multiple sclerosis	6e-05	0.00072	CcSEcCtD
Indomethacin—Thrombocytopenia—Betamethasone—multiple sclerosis	5.98e-05	0.000717	CcSEcCtD
Indomethacin—Thrombocytopenia—Dexamethasone—multiple sclerosis	5.98e-05	0.000717	CcSEcCtD
Indomethacin—Tachycardia—Dexamethasone—multiple sclerosis	5.96e-05	0.000715	CcSEcCtD
Indomethacin—Tachycardia—Betamethasone—multiple sclerosis	5.96e-05	0.000715	CcSEcCtD
Indomethacin—Angioedema—Prednisone—multiple sclerosis	5.95e-05	0.000714	CcSEcCtD
Indomethacin—ABCB1—cerebellum—multiple sclerosis	5.95e-05	0.00205	CbGeAlD
Indomethacin—Dyspepsia—Triamcinolone—multiple sclerosis	5.92e-05	0.000711	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—multiple sclerosis	5.91e-05	0.000709	CcSEcCtD
Indomethacin—Dyspepsia—Methylprednisolone—multiple sclerosis	5.91e-05	0.000709	CcSEcCtD
Indomethacin—Hyperhidrosis—Dexamethasone—multiple sclerosis	5.9e-05	0.000708	CcSEcCtD
Indomethacin—Hyperhidrosis—Betamethasone—multiple sclerosis	5.9e-05	0.000708	CcSEcCtD
Indomethacin—Malaise—Prednisone—multiple sclerosis	5.88e-05	0.000705	CcSEcCtD
Indomethacin—Vertigo—Prednisone—multiple sclerosis	5.85e-05	0.000702	CcSEcCtD
Indomethacin—Syncope—Prednisone—multiple sclerosis	5.84e-05	0.000701	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—multiple sclerosis	5.83e-05	0.0007	CcSEcCtD
Indomethacin—Anorexia—Dexamethasone—multiple sclerosis	5.82e-05	0.000698	CcSEcCtD
Indomethacin—Anorexia—Betamethasone—multiple sclerosis	5.82e-05	0.000698	CcSEcCtD
Indomethacin—Urticaria—Prednisolone—multiple sclerosis	5.81e-05	0.000697	CcSEcCtD
Indomethacin—Fatigue—Triamcinolone—multiple sclerosis	5.8e-05	0.000696	CcSEcCtD
Indomethacin—Fatigue—Methylprednisolone—multiple sclerosis	5.79e-05	0.000694	CcSEcCtD
Indomethacin—Pain—Triamcinolone—multiple sclerosis	5.75e-05	0.00069	CcSEcCtD
Indomethacin—Loss of consciousness—Prednisone—multiple sclerosis	5.73e-05	0.000687	CcSEcCtD
Indomethacin—Hypotension—Betamethasone—multiple sclerosis	5.71e-05	0.000684	CcSEcCtD
Indomethacin—Hypotension—Dexamethasone—multiple sclerosis	5.71e-05	0.000684	CcSEcCtD
Indomethacin—Vomiting—Mitoxantrone—multiple sclerosis	5.67e-05	0.00068	CcSEcCtD
Indomethacin—Convulsion—Prednisone—multiple sclerosis	5.65e-05	0.000677	CcSEcCtD
Indomethacin—Hypertension—Prednisone—multiple sclerosis	5.63e-05	0.000675	CcSEcCtD
Indomethacin—Rash—Mitoxantrone—multiple sclerosis	5.62e-05	0.000675	CcSEcCtD
Indomethacin—Dermatitis—Mitoxantrone—multiple sclerosis	5.62e-05	0.000674	CcSEcCtD
Indomethacin—Headache—Mitoxantrone—multiple sclerosis	5.59e-05	0.00067	CcSEcCtD
Indomethacin—Feeling abnormal—Triamcinolone—multiple sclerosis	5.55e-05	0.000665	CcSEcCtD
Indomethacin—Feeling abnormal—Methylprednisolone—multiple sclerosis	5.53e-05	0.000664	CcSEcCtD
Indomethacin—Anxiety—Prednisone—multiple sclerosis	5.53e-05	0.000663	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—multiple sclerosis	5.53e-05	0.000663	CcSEcCtD
Indomethacin—Insomnia—Betamethasone—multiple sclerosis	5.52e-05	0.000662	CcSEcCtD
Indomethacin—Insomnia—Dexamethasone—multiple sclerosis	5.52e-05	0.000662	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	5.49e-05	0.000659	CcSEcCtD
Indomethacin—Paraesthesia—Dexamethasone—multiple sclerosis	5.48e-05	0.000658	CcSEcCtD
Indomethacin—Paraesthesia—Betamethasone—multiple sclerosis	5.48e-05	0.000658	CcSEcCtD
Indomethacin—Discomfort—Prednisone—multiple sclerosis	5.48e-05	0.000657	CcSEcCtD
Indomethacin—Erythema—Methotrexate—multiple sclerosis	5.45e-05	0.000653	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisolone—multiple sclerosis	5.39e-05	0.000647	CcSEcCtD
Indomethacin—Dyspepsia—Dexamethasone—multiple sclerosis	5.37e-05	0.000645	CcSEcCtD
Indomethacin—Dyspepsia—Betamethasone—multiple sclerosis	5.37e-05	0.000645	CcSEcCtD
Indomethacin—Urticaria—Triamcinolone—multiple sclerosis	5.35e-05	0.000641	CcSEcCtD
Indomethacin—Urticaria—Methylprednisolone—multiple sclerosis	5.33e-05	0.00064	CcSEcCtD
Indomethacin—Body temperature increased—Triamcinolone—multiple sclerosis	5.32e-05	0.000638	CcSEcCtD
Indomethacin—Anaphylactic shock—Prednisone—multiple sclerosis	5.32e-05	0.000638	CcSEcCtD
Indomethacin—Oedema—Prednisone—multiple sclerosis	5.32e-05	0.000638	CcSEcCtD
Indomethacin—Abdominal pain—Methylprednisolone—multiple sclerosis	5.31e-05	0.000637	CcSEcCtD
Indomethacin—Decreased appetite—Betamethasone—multiple sclerosis	5.31e-05	0.000637	CcSEcCtD
Indomethacin—Decreased appetite—Dexamethasone—multiple sclerosis	5.31e-05	0.000637	CcSEcCtD
Indomethacin—Nausea—Mitoxantrone—multiple sclerosis	5.3e-05	0.000636	CcSEcCtD
Indomethacin—Fatigue—Betamethasone—multiple sclerosis	5.26e-05	0.000631	CcSEcCtD
Indomethacin—Fatigue—Dexamethasone—multiple sclerosis	5.26e-05	0.000631	CcSEcCtD
Indomethacin—Shock—Prednisone—multiple sclerosis	5.23e-05	0.000628	CcSEcCtD
Indomethacin—Pain—Betamethasone—multiple sclerosis	5.22e-05	0.000626	CcSEcCtD
Indomethacin—Pain—Dexamethasone—multiple sclerosis	5.22e-05	0.000626	CcSEcCtD
Indomethacin—Tachycardia—Prednisone—multiple sclerosis	5.19e-05	0.000623	CcSEcCtD
Indomethacin—Hyperhidrosis—Prednisone—multiple sclerosis	5.14e-05	0.000617	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—multiple sclerosis	5.13e-05	0.000616	CcSEcCtD
Indomethacin—Anorexia—Prednisone—multiple sclerosis	5.07e-05	0.000608	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—multiple sclerosis	5.05e-05	0.000606	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—multiple sclerosis	5.03e-05	0.000604	CcSEcCtD
Indomethacin—Feeling abnormal—Dexamethasone—multiple sclerosis	5.03e-05	0.000604	CcSEcCtD
Indomethacin—Feeling abnormal—Betamethasone—multiple sclerosis	5.03e-05	0.000604	CcSEcCtD
Indomethacin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	4.99e-05	0.000599	CcSEcCtD
Indomethacin—Gastrointestinal pain—Betamethasone—multiple sclerosis	4.99e-05	0.000599	CcSEcCtD
Indomethacin—Hypersensitivity—Triamcinolone—multiple sclerosis	4.96e-05	0.000595	CcSEcCtD
Indomethacin—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.95e-05	0.000593	CcSEcCtD
Indomethacin—Malaise—Methotrexate—multiple sclerosis	4.91e-05	0.000589	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—multiple sclerosis	4.89e-05	0.000587	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—multiple sclerosis	4.87e-05	0.000585	CcSEcCtD
Indomethacin—Urticaria—Dexamethasone—multiple sclerosis	4.85e-05	0.000582	CcSEcCtD
Indomethacin—Urticaria—Betamethasone—multiple sclerosis	4.85e-05	0.000582	CcSEcCtD
Indomethacin—Dizziness—Prednisolone—multiple sclerosis	4.84e-05	0.00058	CcSEcCtD
Indomethacin—ABCB1—brain—multiple sclerosis	4.83e-05	0.00167	CbGeAlD
Indomethacin—Asthenia—Triamcinolone—multiple sclerosis	4.83e-05	0.000579	CcSEcCtD
Indomethacin—Abdominal pain—Dexamethasone—multiple sclerosis	4.83e-05	0.000579	CcSEcCtD
Indomethacin—Body temperature increased—Betamethasone—multiple sclerosis	4.83e-05	0.000579	CcSEcCtD
Indomethacin—Body temperature increased—Dexamethasone—multiple sclerosis	4.83e-05	0.000579	CcSEcCtD
Indomethacin—Abdominal pain—Betamethasone—multiple sclerosis	4.83e-05	0.000579	CcSEcCtD
Indomethacin—Asthenia—Methylprednisolone—multiple sclerosis	4.82e-05	0.000578	CcSEcCtD
Indomethacin—Insomnia—Prednisone—multiple sclerosis	4.81e-05	0.000577	CcSEcCtD
Indomethacin—Paraesthesia—Prednisone—multiple sclerosis	4.77e-05	0.000573	CcSEcCtD
Indomethacin—Pruritus—Triamcinolone—multiple sclerosis	4.76e-05	0.000571	CcSEcCtD
Indomethacin—Pruritus—Methylprednisolone—multiple sclerosis	4.75e-05	0.00057	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—multiple sclerosis	4.72e-05	0.000566	CcSEcCtD
Indomethacin—Dyspepsia—Prednisone—multiple sclerosis	4.68e-05	0.000561	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—multiple sclerosis	4.64e-05	0.000556	CcSEcCtD
Indomethacin—Decreased appetite—Prednisone—multiple sclerosis	4.62e-05	0.000554	CcSEcCtD
Indomethacin—Rash—Prednisolone—multiple sclerosis	4.61e-05	0.000553	CcSEcCtD
Indomethacin—Dermatitis—Prednisolone—multiple sclerosis	4.61e-05	0.000553	CcSEcCtD
Indomethacin—Diarrhoea—Methylprednisolone—multiple sclerosis	4.59e-05	0.000551	CcSEcCtD
Indomethacin—Fatigue—Prednisone—multiple sclerosis	4.58e-05	0.00055	CcSEcCtD
Indomethacin—Headache—Prednisolone—multiple sclerosis	4.58e-05	0.00055	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—multiple sclerosis	4.58e-05	0.000549	CcSEcCtD
Indomethacin—Constipation—Prednisone—multiple sclerosis	4.55e-05	0.000545	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—multiple sclerosis	4.48e-05	0.000537	CcSEcCtD
Indomethacin—Dizziness—Triamcinolone—multiple sclerosis	4.45e-05	0.000534	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—multiple sclerosis	4.44e-05	0.000533	CcSEcCtD
Indomethacin—Dizziness—Methylprednisolone—multiple sclerosis	4.44e-05	0.000533	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisone—multiple sclerosis	4.38e-05	0.000526	CcSEcCtD
Indomethacin—Asthenia—Dexamethasone—multiple sclerosis	4.38e-05	0.000525	CcSEcCtD
Indomethacin—Asthenia—Betamethasone—multiple sclerosis	4.38e-05	0.000525	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—multiple sclerosis	4.35e-05	0.000522	CcSEcCtD
Indomethacin—Gastrointestinal pain—Prednisone—multiple sclerosis	4.35e-05	0.000522	CcSEcCtD
Indomethacin—Nausea—Prednisolone—multiple sclerosis	4.35e-05	0.000521	CcSEcCtD
Indomethacin—Pruritus—Betamethasone—multiple sclerosis	4.32e-05	0.000518	CcSEcCtD
Indomethacin—Pruritus—Dexamethasone—multiple sclerosis	4.32e-05	0.000518	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—multiple sclerosis	4.3e-05	0.000515	CcSEcCtD
Indomethacin—Vomiting—Triamcinolone—multiple sclerosis	4.28e-05	0.000513	CcSEcCtD
Indomethacin—Vomiting—Methylprednisolone—multiple sclerosis	4.27e-05	0.000512	CcSEcCtD
Indomethacin—Rash—Triamcinolone—multiple sclerosis	4.24e-05	0.000509	CcSEcCtD
Indomethacin—Dermatitis—Triamcinolone—multiple sclerosis	4.24e-05	0.000508	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—multiple sclerosis	4.24e-05	0.000508	CcSEcCtD
Indomethacin—Rash—Methylprednisolone—multiple sclerosis	4.23e-05	0.000508	CcSEcCtD
Indomethacin—Dermatitis—Methylprednisolone—multiple sclerosis	4.23e-05	0.000507	CcSEcCtD
Indomethacin—Urticaria—Prednisone—multiple sclerosis	4.22e-05	0.000507	CcSEcCtD
Indomethacin—Headache—Triamcinolone—multiple sclerosis	4.22e-05	0.000506	CcSEcCtD
Indomethacin—Headache—Methylprednisolone—multiple sclerosis	4.21e-05	0.000505	CcSEcCtD
Indomethacin—Abdominal pain—Prednisone—multiple sclerosis	4.2e-05	0.000504	CcSEcCtD
Indomethacin—Body temperature increased—Prednisone—multiple sclerosis	4.2e-05	0.000504	CcSEcCtD
Indomethacin—Diarrhoea—Dexamethasone—multiple sclerosis	4.18e-05	0.000501	CcSEcCtD
Indomethacin—Diarrhoea—Betamethasone—multiple sclerosis	4.18e-05	0.000501	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—multiple sclerosis	4.15e-05	0.000498	CcSEcCtD
Indomethacin—Dizziness—Betamethasone—multiple sclerosis	4.04e-05	0.000484	CcSEcCtD
Indomethacin—Dizziness—Dexamethasone—multiple sclerosis	4.04e-05	0.000484	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—multiple sclerosis	4.02e-05	0.000482	CcSEcCtD
Indomethacin—Nausea—Triamcinolone—multiple sclerosis	4e-05	0.000479	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—multiple sclerosis	3.99e-05	0.000479	CcSEcCtD
Indomethacin—Nausea—Methylprednisolone—multiple sclerosis	3.99e-05	0.000478	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—multiple sclerosis	3.96e-05	0.000475	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—multiple sclerosis	3.95e-05	0.000474	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisone—multiple sclerosis	3.92e-05	0.00047	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—multiple sclerosis	3.91e-05	0.000469	CcSEcCtD
Indomethacin—Vomiting—Betamethasone—multiple sclerosis	3.88e-05	0.000466	CcSEcCtD
Indomethacin—Vomiting—Dexamethasone—multiple sclerosis	3.88e-05	0.000466	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—multiple sclerosis	3.86e-05	0.000463	CcSEcCtD
Indomethacin—Rash—Dexamethasone—multiple sclerosis	3.85e-05	0.000462	CcSEcCtD
Indomethacin—Rash—Betamethasone—multiple sclerosis	3.85e-05	0.000462	CcSEcCtD
Indomethacin—Dermatitis—Betamethasone—multiple sclerosis	3.85e-05	0.000461	CcSEcCtD
Indomethacin—Dermatitis—Dexamethasone—multiple sclerosis	3.85e-05	0.000461	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—multiple sclerosis	3.83e-05	0.00046	CcSEcCtD
Indomethacin—Headache—Dexamethasone—multiple sclerosis	3.83e-05	0.000459	CcSEcCtD
Indomethacin—Headache—Betamethasone—multiple sclerosis	3.83e-05	0.000459	CcSEcCtD
Indomethacin—Asthenia—Prednisone—multiple sclerosis	3.82e-05	0.000458	CcSEcCtD
Indomethacin—Pain—Methotrexate—multiple sclerosis	3.8e-05	0.000456	CcSEcCtD
Indomethacin—Pruritus—Prednisone—multiple sclerosis	3.76e-05	0.000451	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—multiple sclerosis	3.66e-05	0.000439	CcSEcCtD
Indomethacin—Diarrhoea—Prednisone—multiple sclerosis	3.64e-05	0.000436	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—multiple sclerosis	3.63e-05	0.000436	CcSEcCtD
Indomethacin—Nausea—Dexamethasone—multiple sclerosis	3.63e-05	0.000435	CcSEcCtD
Indomethacin—Nausea—Betamethasone—multiple sclerosis	3.63e-05	0.000435	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—multiple sclerosis	3.53e-05	0.000423	CcSEcCtD
Indomethacin—Dizziness—Prednisone—multiple sclerosis	3.52e-05	0.000422	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—multiple sclerosis	3.51e-05	0.000421	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—multiple sclerosis	3.51e-05	0.000421	CcSEcCtD
Indomethacin—Vomiting—Prednisone—multiple sclerosis	3.38e-05	0.000406	CcSEcCtD
Indomethacin—Rash—Prednisone—multiple sclerosis	3.35e-05	0.000402	CcSEcCtD
Indomethacin—Dermatitis—Prednisone—multiple sclerosis	3.35e-05	0.000402	CcSEcCtD
Indomethacin—Headache—Prednisone—multiple sclerosis	3.33e-05	0.0004	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—multiple sclerosis	3.27e-05	0.000393	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—multiple sclerosis	3.19e-05	0.000382	CcSEcCtD
Indomethacin—Nausea—Prednisone—multiple sclerosis	3.16e-05	0.000379	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—multiple sclerosis	3.14e-05	0.000377	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—multiple sclerosis	3.04e-05	0.000365	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—multiple sclerosis	2.94e-05	0.000353	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—multiple sclerosis	2.83e-05	0.000339	CcSEcCtD
Indomethacin—Rash—Methotrexate—multiple sclerosis	2.8e-05	0.000336	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—multiple sclerosis	2.8e-05	0.000336	CcSEcCtD
Indomethacin—Headache—Methotrexate—multiple sclerosis	2.78e-05	0.000334	CcSEcCtD
Indomethacin—Nausea—Methotrexate—multiple sclerosis	2.64e-05	0.000317	CcSEcCtD
Indomethacin—SLC10A1—Metabolism—APOE—multiple sclerosis	8.8e-06	0.000122	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCR3—multiple sclerosis	8.76e-06	0.000121	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.75e-06	0.000121	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.75e-06	0.000121	CbGpPWpGaD
Indomethacin—PPARA—Generic Transcription Pathway—MYC—multiple sclerosis	8.71e-06	0.00012	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	8.7e-06	0.00012	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CD28—multiple sclerosis	8.67e-06	0.00012	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.61e-06	0.000119	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCR2—multiple sclerosis	8.52e-06	0.000118	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.36e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.32e-06	0.000115	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.32e-06	0.000115	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—ITGA4—multiple sclerosis	8.28e-06	0.000114	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.27e-06	0.000114	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—BCHE—multiple sclerosis	8.27e-06	0.000114	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—BCHE—multiple sclerosis	8.27e-06	0.000114	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IFNB1—multiple sclerosis	8.22e-06	0.000114	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TGFB1—multiple sclerosis	8.18e-06	0.000113	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD80—multiple sclerosis	8.17e-06	0.000113	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.16e-06	0.000113	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL2—multiple sclerosis	8.14e-06	0.000112	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—ALB—multiple sclerosis	8.11e-06	0.000112	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL6—multiple sclerosis	8.1e-06	0.000112	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD28—multiple sclerosis	8.09e-06	0.000112	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP27B1—multiple sclerosis	8.08e-06	0.000112	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP24A1—multiple sclerosis	8.08e-06	0.000112	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MAPK1—multiple sclerosis	8.02e-06	0.000111	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—POMC—multiple sclerosis	8e-06	0.00011	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.9e-06	0.000109	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	7.9e-06	0.000109	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CNR1—multiple sclerosis	7.86e-06	0.000109	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CD86—multiple sclerosis	7.85e-06	0.000108	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.82e-06	0.000108	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—BCHE—multiple sclerosis	7.82e-06	0.000108	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.8e-06	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL5—multiple sclerosis	7.72e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	7.72e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MMP9—multiple sclerosis	7.7e-06	0.000106	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—multiple sclerosis	7.63e-06	0.000105	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.62e-06	0.000105	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—RRM1—multiple sclerosis	7.57e-06	0.000105	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—APOE—multiple sclerosis	7.57e-06	0.000105	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—POMC—multiple sclerosis	7.56e-06	0.000104	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—VDR—multiple sclerosis	7.56e-06	0.000104	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.52e-06	0.000104	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.4e-06	0.000102	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPC5—multiple sclerosis	7.39e-06	0.000102	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IL2—multiple sclerosis	7.33e-06	0.000101	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—POMC—multiple sclerosis	7.26e-06	0.0001	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	7.26e-06	0.0001	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	7.26e-06	0.0001	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.24e-06	0.0001	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—BCHE—multiple sclerosis	7.2e-06	9.95e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SPP1—multiple sclerosis	7.15e-06	9.88e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.15e-06	9.87e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP9—multiple sclerosis	7.11e-06	9.82e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.11e-06	9.82e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCL2—multiple sclerosis	7.11e-06	9.81e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RPL5—multiple sclerosis	7.09e-06	9.8e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.09e-06	9.8e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	7.08e-06	9.78e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	7.08e-06	9.78e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCL10—multiple sclerosis	7.08e-06	9.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.99e-06	9.65e-05	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.97e-06	9.63e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCR5—multiple sclerosis	6.96e-06	9.61e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TYK2—multiple sclerosis	6.9e-06	9.53e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ALB—multiple sclerosis	6.9e-06	9.53e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2RA—multiple sclerosis	6.86e-06	9.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.86e-06	9.47e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—STAT3—multiple sclerosis	6.85e-06	9.46e-05	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.83e-06	9.44e-05	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.81e-06	9.41e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SLC11A1—multiple sclerosis	6.8e-06	9.39e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—BCHE—multiple sclerosis	6.72e-06	9.28e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—BCHE—multiple sclerosis	6.72e-06	9.28e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPC5—multiple sclerosis	6.64e-06	9.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	6.62e-06	9.14e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	6.62e-06	9.14e-05	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.6e-06	9.11e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—APOE—multiple sclerosis	6.56e-06	9.07e-05	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.52e-06	9e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.51e-06	9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.51e-06	8.99e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—POMC—multiple sclerosis	6.5e-06	8.98e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—BCHE—multiple sclerosis	6.48e-06	8.95e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPC5—multiple sclerosis	6.48e-06	8.95e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.47e-06	8.93e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TYK2—multiple sclerosis	6.45e-06	8.91e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.43e-06	8.88e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MYC—multiple sclerosis	6.37e-06	8.79e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.36e-06	8.78e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TGFB1—multiple sclerosis	6.35e-06	8.77e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—APOE—multiple sclerosis	6.33e-06	8.74e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—STAT3—multiple sclerosis	6.32e-06	8.73e-05	CbGpPWpGaD
Indomethacin—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	6.24e-06	8.62e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD4—multiple sclerosis	6.24e-06	8.62e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MAPK1—multiple sclerosis	6.23e-06	8.6e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.19e-06	8.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CD86—multiple sclerosis	6.19e-06	8.55e-05	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—multiple sclerosis	6.16e-06	8.51e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—BCHE—multiple sclerosis	6.16e-06	8.51e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—RRM1—multiple sclerosis	6.13e-06	8.46e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL5—multiple sclerosis	6.09e-06	8.42e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.05e-06	8.36e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ALB—multiple sclerosis	5.93e-06	8.19e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL2—multiple sclerosis	5.91e-06	8.17e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.87e-06	8.11e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TGFB1—multiple sclerosis	5.86e-06	8.09e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.8e-06	8.01e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD86—multiple sclerosis	5.77e-06	7.97e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MAPK1—multiple sclerosis	5.75e-06	7.94e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CD80—multiple sclerosis	5.72e-06	7.91e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TGFB1—multiple sclerosis	5.72e-06	7.89e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2RA—multiple sclerosis	5.66e-06	7.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SPP1—multiple sclerosis	5.64e-06	7.79e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—POMC—multiple sclerosis	5.64e-06	7.79e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—MAPK1—multiple sclerosis	5.6e-06	7.74e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RRM1—multiple sclerosis	5.5e-06	7.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCR5—multiple sclerosis	5.49e-06	7.58e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—BCHE—multiple sclerosis	5.48e-06	7.57e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—multiple sclerosis	5.47e-06	7.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—POMC—multiple sclerosis	5.44e-06	7.51e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD28—multiple sclerosis	5.43e-06	7.5e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2RA—multiple sclerosis	5.41e-06	7.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2—multiple sclerosis	5.37e-06	7.42e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RRM1—multiple sclerosis	5.37e-06	7.41e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL2—multiple sclerosis	5.32e-06	7.35e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ALB—multiple sclerosis	5.14e-06	7.1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CCR5—multiple sclerosis	5.12e-06	7.07e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.05e-06	6.97e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.02e-06	6.93e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.01e-06	6.93e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—APOE—multiple sclerosis	4.99e-06	6.9e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HLA-A—multiple sclerosis	4.99e-06	6.89e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—APOE—multiple sclerosis	4.98e-06	6.87e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—APOE—multiple sclerosis	4.98e-06	6.87e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.95e-06	6.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.94e-06	6.82e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.92e-06	6.8e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.84e-06	6.69e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TYK2—multiple sclerosis	4.83e-06	6.67e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—STAT3—multiple sclerosis	4.83e-06	6.67e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—multiple sclerosis	4.79e-06	6.61e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.75e-06	6.56e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—APOE—multiple sclerosis	4.7e-06	6.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APOE—multiple sclerosis	4.65e-06	6.43e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.61e-06	6.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.6e-06	6.36e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CD80—multiple sclerosis	4.52e-06	6.24e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MYC—multiple sclerosis	4.49e-06	6.2e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFB1—multiple sclerosis	4.48e-06	6.19e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—multiple sclerosis	4.42e-06	6.1e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MAPK1—multiple sclerosis	4.39e-06	6.07e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—BCHE—multiple sclerosis	4.35e-06	6.01e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—APOE—multiple sclerosis	4.33e-06	5.98e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—POMC—multiple sclerosis	4.29e-06	5.93e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—POMC—multiple sclerosis	4.27e-06	5.9e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—POMC—multiple sclerosis	4.27e-06	5.9e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.27e-06	5.89e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD80—multiple sclerosis	4.21e-06	5.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL2—multiple sclerosis	4.2e-06	5.8e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MYC—multiple sclerosis	4.19e-06	5.79e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—MAPK1—multiple sclerosis	4.11e-06	5.67e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.08e-06	5.64e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOE—multiple sclerosis	4.04e-06	5.58e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOE—multiple sclerosis	4.04e-06	5.58e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—POMC—multiple sclerosis	4.04e-06	5.58e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2—multiple sclerosis	4.02e-06	5.55e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOE—multiple sclerosis	3.9e-06	5.38e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—multiple sclerosis	3.9e-06	5.38e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ALB—multiple sclerosis	3.9e-06	5.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.89e-06	5.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD86—multiple sclerosis	3.87e-06	5.35e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TYK2—multiple sclerosis	3.81e-06	5.26e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—multiple sclerosis	3.81e-06	5.26e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—POMC—multiple sclerosis	3.72e-06	5.14e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—multiple sclerosis	3.7e-06	5.12e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—multiple sclerosis	3.68e-06	5.09e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.67e-06	5.06e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TYK2—multiple sclerosis	3.55e-06	4.91e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—BCHE—multiple sclerosis	3.52e-06	4.86e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—POMC—multiple sclerosis	3.47e-06	4.8e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—POMC—multiple sclerosis	3.47e-06	4.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CCR5—multiple sclerosis	3.43e-06	4.74e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—multiple sclerosis	3.39e-06	4.69e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—multiple sclerosis	3.38e-06	4.67e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—multiple sclerosis	3.37e-06	4.66e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—POMC—multiple sclerosis	3.35e-06	4.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HLA-A—multiple sclerosis	3.35e-06	4.62e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.34e-06	4.62e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.34e-06	4.62e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—multiple sclerosis	3.32e-06	4.58e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—multiple sclerosis	3.3e-06	4.55e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—multiple sclerosis	3.21e-06	4.44e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—POMC—multiple sclerosis	3.18e-06	4.4e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—multiple sclerosis	3.17e-06	4.38e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—multiple sclerosis	3.17e-06	4.37e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—multiple sclerosis	3.17e-06	4.37e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—BCHE—multiple sclerosis	3.16e-06	4.36e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—multiple sclerosis	3.16e-06	4.36e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—multiple sclerosis	3.14e-06	4.34e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—multiple sclerosis	3.14e-06	4.33e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—multiple sclerosis	3.12e-06	4.32e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.1e-06	4.28e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—BCHE—multiple sclerosis	3.08e-06	4.26e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—multiple sclerosis	3.08e-06	4.25e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—multiple sclerosis	3.05e-06	4.22e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.05e-06	4.21e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—multiple sclerosis	3e-06	4.15e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—multiple sclerosis	3e-06	4.15e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—multiple sclerosis	2.9e-06	4.01e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.88e-06	3.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—multiple sclerosis	2.83e-06	3.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD80—multiple sclerosis	2.82e-06	3.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—multiple sclerosis	2.67e-06	3.69e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—multiple sclerosis	2.62e-06	3.61e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—multiple sclerosis	2.59e-06	3.57e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—multiple sclerosis	2.58e-06	3.57e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—multiple sclerosis	2.54e-06	3.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—multiple sclerosis	2.49e-06	3.44e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—multiple sclerosis	2.48e-06	3.43e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—multiple sclerosis	2.47e-06	3.42e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—multiple sclerosis	2.43e-06	3.35e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TYK2—multiple sclerosis	2.38e-06	3.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—multiple sclerosis	2.36e-06	3.26e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—multiple sclerosis	2.31e-06	3.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—multiple sclerosis	2.31e-06	3.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—multiple sclerosis	2.26e-06	3.12e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—multiple sclerosis	2.25e-06	3.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—multiple sclerosis	2.16e-06	2.98e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—multiple sclerosis	2.12e-06	2.92e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—multiple sclerosis	2.05e-06	2.83e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—multiple sclerosis	1.9e-06	2.62e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—multiple sclerosis	1.86e-06	2.57e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—multiple sclerosis	1.85e-06	2.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—multiple sclerosis	1.82e-06	2.51e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—multiple sclerosis	1.74e-06	2.4e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—multiple sclerosis	1.73e-06	2.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—multiple sclerosis	1.67e-06	2.31e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—multiple sclerosis	1.63e-06	2.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—multiple sclerosis	1.59e-06	2.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—multiple sclerosis	1.55e-06	2.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—multiple sclerosis	1.55e-06	2.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—multiple sclerosis	1.52e-06	2.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—multiple sclerosis	1.49e-06	2.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—multiple sclerosis	1.49e-06	2.06e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—multiple sclerosis	1.45e-06	2.01e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—multiple sclerosis	1.36e-06	1.87e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—multiple sclerosis	1.17e-06	1.61e-05	CbGpPWpGaD
